B
Brian Bieber
Publications - 122
Citations - 3423
Brian Bieber is an academic researcher. The author has contributed to research in topics: Dialysis & Hemodialysis. The author has an hindex of 26, co-authored 103 publications receiving 2439 citations.
Papers
More filters
Journal ArticleDOI
Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.
Francesca Tentori,Mia Wang,Brian Bieber,Angelo Karaboyas,Yun Li,Stefan H. Jacobson,Vittorio E. Andreucci,Masafumi Fukagawa,Luc Frimat,David C. Mendelssohn,Friedrich K. Port,Ronald L. Pisoni,Bruce M. Robinson +12 more
TL;DR: In a large international sample of patients on hemodialysis, parathyroid hormone levels increased in most countries, and secondary hyperparathyroidism treatments changed over time, and very low and very high parathyro hormone levels were associated with adverse outcomes.
Journal ArticleDOI
Sex-Specific Differences in Hemodialysis Prevalence and Practices and the Male-to-Female Mortality Rate: The Dialysis Outcomes and Practice Patterns Study (DOPPS)
Manfred Hecking,Brian Bieber,Jean Ethier,Alexandra Kautzky-Willer,Gere Sunder-Plassmann,Marcus D. Säemann,Sylvia P. B. Ramirez,Brenda W. Gillespie,Ronald L. Pisoni,Bruce M. Robinson,Friedrich K. Port +10 more
TL;DR: The results show that women's survival advantage was markedly diminished in hemodialysis patients, and sex interactions with mortality were markedly diminished.
Journal ArticleDOI
Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality.
George R. Bailie,Maria Larkina,David A. Goodkin,Yun Li,Ronald L. Pisoni,Brian Bieber,Nancy A. Mason,Lin Tong,Francesco Locatelli,Mark R. Marshall,Masaaki Inaba,Bruce M. Robinson +11 more
TL;DR: Adjusted Cox regression was used to analyze associations between IV iron dose and clinical outcomes in hemodialysis patients in 12 countries from 2002 to 2011 and found hospitalization risk was elevated among patients receiving 300 mg/month or more, and the safety of different IV iron-dosing strategies in HD patients is urgently needed.
Journal ArticleDOI
Hepatitis C infection is very rarely treated among hemodialysis patients.
TL;DR: Karger et al. as discussed by the authors evaluated the extent and outcome of hepatitis C virus (HCV) therapy among hemodialysis (HD) patients and found that only 48 (1.0%) of the 4,589 HCV+ patients with prescription data were receiving antiviral medication.
Journal ArticleDOI
C-Reactive Protein and Prediction of 1-Year Mortality in Prevalent Hemodialysis Patients
Jonathan Bazeley,Brian Bieber,Yun Li,Hal Morgenstern,Patricia de Sequera,Christian Combe,Hiroyasu Yamamoto,Martin Gallagher,Friedrich K. Port,Bruce M. Robinson +9 more
TL;DR: The value of measuring CRP in addition to standard inflammatory biomarkers to improve mortality prediction in hemodialysis patients is demonstrated, and the association of CRP with mortality is evaluated.